NCT05567757View on ClinicalTrials.gov

Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

March 30, 2025

Study Completion Date

March 30, 2025

Conditions
End Stage Renal Disease
Interventions
BIOLOGICAL

Arteriovenous conduit implant

Study subjects will be implanted with an arteriovenous shunt for hemodialysis access in the upper extremity

Trial Locations (1)

Unknown

Centro de Asistencia Renal, Río Hato

All Listed Sponsors
lead

Vascudyne, Inc.

INDUSTRY